Dr. Lechowicz is the program director of the Winship Summer Scholars Program, providing high school students with a unique immersion experience in a cancer research laboratory.
Titles and Roles
- Associate Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Dr. Lechowicz joined Emory from the Sidney Kimmel Cancer Center at Johns Hopkins University where she completed a post-doctoral fellowship in oncology. She is board certified in Internal Medicine. Dr. Lechowicz's research interests are in hematologic malignancies. She has been a principal investigator and co-principal investigator on a number of national and international clinical trials involving the treatment of patients with virally related cancers and lymphomas.
Dr. Lechowicz is currently active in the American Society of Clinical Oncology, the Discovery and Developmental Therapeutics Research Program, the American Society of Hematology, and the American Association of Cancer Research. She also serves on the Board of Directors of the International Center for the Integration of Health and Spirituality.
Dr. Lechowicz earned her medical degree from SUNY-Syracuse in Syracuse, New York. She then completed her internship and fellowship at Columbia Presbyterian Medical Center in New York, New York followed by a fellowship at John Hopkins Affiliated Hospital in Baltimore, Maryland.
Dr. Lechowicz's research interests are in hematologic malignancies specifically T cell lymphomas. Her interest in HIV and malignancies began with her training at Johns Hopkins. She is the primary investigator for a number of trials at Emory University with regard to improvement of care in non-Hodgkin's lymphomas, particularly related to transplantation and diffused B-cell lymphomas; cutaneous and peripheral lymphomas; T-cell lymphomas; and HIV and lymphoma care.
Dr. Lechowicz was editor for the American Society of Hematology Daily News in 2010. She has served on multiple committees including the United States Cutaneous Lymphoma Consortium, American Society of Hematology, the ethics committee at Columbia Presbyterian Medical Center at Johns Hopkins, the ECOG Core Committee, and the Lymphoma Research Foundation’s Lymphoma Awareness Multicultural Population Advisory Committee.